PRL and periodontal disorder: One of those retrospective cohort studies [30] found a higher prevalence of periodontal disease after a year of treatment with prolactin‐inducing SGAs (amisulpride, risperidone, and paliperidone) compared with prolactin‐sparing SGAs (clozapine, quetiapine, olanzapine, ziprasidone, and aripiprazole) or no treatment.